MARX Biotech , Ltd. Return on Equity

The latest ROE for 7731.TWO is 16.64%. That is below the Consumer Discretionary sector average of 23.23%. Investors often review this figure alongside MARX Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against Consumer Discretionary companies, 7731.TWO currently prints 16.64% for ROE, while the sector average sits near 23.23%. That is roughly 28.4% below the sector mean. Large gaps often invite a closer look at MARX Biotech , Ltd.'s growth, margins, and balance sheet.

Return on Equity shows how effectively MARX Biotech , Ltd. converts resources into returns. At 16.64%, 7731.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 7731.TWO's ROE (16.64%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack MARX Biotech , Ltd.'s ROE against similar Consumer Discretionary names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Discretionary companies and their key multiples and fundamentals.